目經眼藥水 - 12mL Mujing Eye Drops - 12mL

百年傳承·香港製造

綠寶【目經眼藥水】傳承於清代中醫眼科經典巨著《目經大成》之精萃，是一個經百年傳承及長期臨床驗證的經典優秀產品，能夠起到養護和治療眼病的作用，產品適用於男女老幼：對青少年的近視眼；青中年人的乾眼症、視疲勞、老花眼與電光性眼炎；以及對日益增多的眼底病(如：糖尿病視網膜病變、黃斑病、白內障、青光眼等)療效顯著，並對預防眼及腦中風有良好的效果。是目前國際市場較罕有，且具養護與治療性的純天然中藥眼藥水。

香港 · 瑞士綠寶大藥廠是一家具歷史專注研發天然中藥眼科藥物的藥廠，一直以來投下以億計巨資於眼科醫藥的發展。經歷近三十年的發展，擁有“原創核心獨家技術”的專有工藝。傳承製造獨家產品使用100%純天然中藥，不含類固醇的綠寶【目經眼藥水】，經過前所未有的標準化處理，通過一系列嚴謹，近乎苛刻的無菌標準製造、檢驗和鑒定，正式成為香港註冊中成藥產品(中成藥註冊編號:HKP-12333)，可能是唯一能通過香港衛生署中成藥註冊的中藥眼藥水，也是世界上罕有的以天然中藥能治療眼底病(例如：糖尿病視網膜病變、黃斑病、白內障、青光眼)的藥物產品。

近年糖尿病患者與各類眼疾不斷急速增長，各國政府有關部門意識到有關情況將導致產生大量因視力障礙而喪失活動能力的人群，以國家的層面研究，國家將損失巨額的生產力GDP增長，產生大量社會問題，也同時產生巨額的醫療開支，隨著進入老年化年代，黃斑病、青光眼、白內障的預防與治療將放上議事日程，因此各類眼疾及眼底病已成為各國重點研究及發展的課題項目。

中醫的活血化瘀，以通為用與眼底病的病因病機相互吻合

眼底是由視網膜、眼底血管、視神經乳頭、視神經纖維、視網膜上的黃斑部，以及視網膜後的脈絡膜等構成，這些部位的病變統稱為眼底病。主要大部份眼底病包括糖尿病性視網膜病變、黃斑病變都是基於眼底循環不佳，水腫，出血所引致疾病，而治療這些非手術能處理的難題，正是配合中醫藥治療的病機“以通為用，活通經脈，促進眼底血液循環”充份發揮了中醫藥在眼科養護和治療上獨特的專長。

綠寶【目經眼藥水】是集中醫藥眼科藥之精髓、配方之精純、工藝之獨特、檢驗之嚴謹、治療之精巧、療效之迅捷於一身的中醫藥經典產品。為解決現今世界級重點難題的眼底病變，作出貢獻。

綠寶【目經眼藥水】– 年事記錄

(1)  傳承百年歷史，獨特工藝，療效顯著；

(2)  1982年起開始進入現代化研究及改良優化；

(3)  2003年開始香港中成藥過渡性註冊，並進行一系列檢驗和鑒定；

(4)  2009年獲得國家科技部基礎專項  (編號：2009FY220100)；

(5)  2013年成為國家十二·五科技重點研發項目(編號：2013BAH08F04、  2013BAH08F00)；

(6)  2013年在世衛組織第51屆世界傳統醫學大會中發表論文，並獲傑出名醫獎。

(7)  2014年獲發國家研究資金，建立研究平台進行項目的研究開發。

(8)  2015年10月中國中央電視台CCTV半小時專訪綠寶【目經眼藥水】。

(9)  2015年中國軍事後勤保障新技術與新裝備入選產品。

(10)  2016年1月香港衛生署正式發出中成藥註冊證書（編號：HKP-12333）。

Centennial Legacy · Made in Hong Kong

Green宝 [Mujing Eye Drops] inherits the essence of the Qing Dynasty's classic ophthalmological masterpiece "Mujing Dacheng" (《目经大成》). This century-old, clinically validated product combines eye care and therapeutic efficacy, suitable for all ages:

• Youth: Myopia (nearsightedness)

• Adults: Dry eye syndrome, eye fatigue, presbyopia, and photoelectric conjunctivitis

• Elderly: Significant efficacy against increasingly common fundus diseases (e.g., diabetic retinopathy, macular degeneration, cataracts, glaucoma)

• Prevention: Supports prevention of ocular and cerebral strokes

It stands as a rare globally available purely natural herbal eye drop with both preventive and therapeutic functions.

Hong Kong · Swiss Green宝 Pharmaceutical

A historically dedicated manufacturer focused on developing natural herbal ophthalmological medicines. With investments exceeding billions in eye care R&D, the company has pioneered "original core proprietary technology" over nearly three decades.

Green宝 [Mujing Eye Drops] is:

• Made from 100% pure natural herbs (no steroids)

• Standardized through unprecedented rigorous processes

• Manufactured, tested, and certified under stringent sterile standards

• Officially registered as a Chinese proprietary medicine in Hong Kong (HKCMM Registration No.: HKP-12333)

• Likely the only herbal eye drop approved by the Hong Kong Department of Health

• A rare global drug capable of treating fundus diseases (e.g., diabetic retinopathy, macular degeneration, cataracts, glaucoma) with natural ingredients

Global Relevance

With rapidly rising cases of diabetes and eye diseases, governments recognize the impending crisis: vision loss may lead to massive productivity declines (GDP loss), social challenges, and soaring medical costs. As populations age, macular degeneration, glaucoma, and cataracts have become priority research areas worldwide.

TCM Theory & Fundus Diseases

Fundus structures include the retina, blood vessels, optic disc, nerve fibers, macula, and choroid. Diseases here are termed "fundus diseases." Most—like diabetic retinopathy and macular degeneration—stem from poor microcirculation, edema, or hemorrhage.

TCM’s philosophy of “activating blood flow, resolving stasis, and unblocking meridians” aligns perfectly with these conditions. Herbal medicine uniquely promotes fundus blood circulation, addressing nonsurgical challenges effectively.

Green宝 [Mujing Eye Drops] Highlights

• Embodies the精髓 (essence) of TCM ophthalmology

• Pure formulation, unique工艺 (technology), rigorous testing

• Rapid efficacy and precise therapeutic targeting

• Contributes to solving world-class fundus disease challenges

Historical Milestones

1. Centennial legacy with unique工艺 and proven efficacy

2. 1982: Began modernized research and optimization

3. 2003: Initiated transitional registration in Hong Kong with series of tests

4. 2009: Awarded National Ministry of Science and Technology Basic Project (No.: 2009FY220100)

5. 2013: Included in China’s 12th Five-Year Plan key R&D projects (No.: 2013BAH08F04, 2013BAH08F00)

6. 2013: Paper presented at WHO’s 51st World Congress on Traditional Medicine; awarded “Outstanding Physician Award”

7. 2014: Received state research funding to establish R&D platforms

8. Oct 2015: Featured in a 30-minute CCTV special report

9. 2015: Selected as new technology/equipment for Chinese military logistics support

10. Jan 2016: Officially granted HKCMM registration (No.: HKP-12333) by Hong Kong Department of Health

Disclaimer: This product is a registered herbal medicine and not intended to replace professional medical advice. Consult a healthcare provider for specific conditions.